Angioplasty and urology sales blamed on Pfizer revenue dip
This article was originally published in Clinica
Pfizer recorded sales of $347 million in its medtech sector in the third quarter, up only 1% on the previous period.
You may also be interested in...
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.